Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model

Abstract

Introduction Breast cancer staging with sentinel lymph node biopsy relies on the use of radioisotopes, which limits the availability of the procedure worldwide. The use of a magnetic nanoparticle tracer and a handheld magnetometer provides a radiation-free alternative, which was recently evaluated in two clinical trials. The hydrodynamic particle size of the used magnetic tracer differs substantially from the radioisotope tracer and could therefore benefit from optimization. The aim of this study was to assess the performance of three different-sized magnetic nanoparticle tracers for sentinel lymph node biopsy within an in vivo porcine model. Materials and methods Sentinel lymph node biopsy was performed within a validated porcine model using three magnetic nanoparticle tracers, approved for use in humans (ferumoxytol, with hydrodynamic diameter d H =32 nm; Sienna+ ® , d H =59 nm; and ferumoxide, d H =111 nm), and a handheld magnetometer. Magnetometer counts (transcutaneous and ex vivo), iron quantification (vibrating sample magnetometry), and histopathological assessments were performed on all ex vivo nodes. Results Transcutaneous “hotspots” were present in 12/12 cases within 30 minutes of injection for the 59 nm tracer, compared to 7/12 for the 32 nm tracer and 8/12 for the 111 nm tracer, at the same time point. Ex vivo magnetometer counts were significantly greater for the 59 nm tracer than for the other tracers. Significantly more nodes per basin were excised for the 32 nm tracer compared to other tracers, indicating poor retention of the 32 nm tracer. Using the 59 nm tracer resulted in a significantly higher iron accumulation compared to the 32 nm tracer. Conclusion The 59 nm tracer demonstrated rapid lymphatic uptake, retention in the first nodes reached, and accumulation in high concentration, making it the most suitable tracer for intraoperative sentinel lymph node localization.

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

“…This may be attributable to the standardized use of dual tracer mapping, surgeon experience, and our practice of defining palpably abnormal nodes as sentinel nodes. Successful mapping is known to be affected by both technique and structural composition of tracers, 18–20 and surgeon experience and comfort with the procedure has been proposed as a significant factor in the identification of sentinel nodes. 21 Despite use of dual tracer technique, 2% of patients failed mapping, identical to reported failed mapping rates in studies of upfront surgery.…”

Skeleton labeled ¹³C-carbon nanoparticles for the imaging and quantification in tumor drainage lymph nodes

“…Dozens of papers have demonstrated the lymph node mapping by CNSI. [1][2][3][4][5][6][7] Other particles, such as carbon dots, 27 magnetic nanoparticles 28 and semiconductor quantum dots, 29 also showed migration toward TDLN. In addition, the imaging of lymph nodes was achieved using CNSI, too.…”

Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol

“…The particles have a carboxydextran coating and a mean hydrodynamic diameter of 59 nm (Z-averaged diameter). 24 Before tracer injection, transverse images were obtained using T 1 weighted turbo spin echo (TSE) sequence (repetition time (TR)/ echo time (TE) 734/16 ms; flip angle (FA) 90°; slice thickness 3.0 mm; field of view 30 cm; matrix 320 3 320 pixels; imaging time approximately 4 min). In addition, a T 1 weighted TSE sequence in the coronal plane (TR/TE 727/16 ms; FA 90°; slice thickness 3.0 mm; field of view 30 cm; matrix 3203320 pixels imaging time 3 min) was obtained to distinguish LNs located closely to each other.…”